We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrahigh Field MRI Technology Provides More Effective Diagnosis of Breast Cancer

By HospiMedica International staff writers
Posted on 19 Mar 2014
Austrian scientists have demonstrated for the first time that a 7-Tesla ultrahigh-field magnetic resonance imaging (MRI) can be used for clinical applications in patients with breast tumors. More...
This may in help, in the near future, to provide a more effective breast cancer diagnosis.

The scientists’ study was published in the April 2014 issue of the journal European Radiology. In earlier research involving 7-Tesla MRI, the clinical application of the technology had been restricted to only one breast due to the limited coil technology available. “The new generation of coils allows clinical application on both sides,” explained Dr. Katja Pinker from the MedUni Vienna department of radiology and nuclear medicine, department of molecular imaging at the Medical University of Vienna (MedUni; Vienna; Austria), where the study was performed in collaboration with the High Field MR Center of Excellence and the Breast Health Center at the MedUni Vienna and Vienna General Hospital.

The 7-Tesla MRI scanner has a high diagnostic accuracy of 96.6%. Dr. Pinker stated, “The higher signal available with 7T [7 Tesla] permits a higher resolution, allowing fine details to be visualized better and a more certain diagnosis to be made. Diagnosis at molecular and metabolic level is also possible with diffusion-weighted or sodium imaging and spectroscopy, helping us to characterize tumors even more effectively.”

The overall outcome of the findings was that bilateral ultrahigh-field MRI of the breast with 7-Tesla can be used clinically without difficulties and “allows patients with breast tumors to be diagnosed more accurately,” the Dr. Pinker. “The future enhancement of ultrahigh-field MRI of the breast with 7-Tesla using molecular and metabolic imaging could represent a further step towards personalized medicine, since not every type of breast cancer is the same.”

By way of comparison, the current clinical standard MRI scans using a 3-Tesla device produce a diagnostic accuracy of up to 93% with the best equipment. The scanning time is also the same, whether it is a 3-Tesla or 7-Tesla MR scanner. The patient spends just over 15 minutes in the tunnel.

The clinical use of 7-Tesla in the examination of breast tumors is therefore possible immediately; however, it also depends on the availability of suitable equipment. Worldwide, there are only eight university institutions that have a 7-Tesla device, including one at the MedUni Vienna/Vienna General Hospital. The 7-Tesla MRI scanner has been around for five years at the MedUni Vienna, and it is the only device of its kind in Austria. The Center of Excellence for High Field MR is one of the world’s leading facilities for this technology.

Related Links:

Medical University of Vienna



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.